As people in the world know, Pfizer and BioNTech succeded to develop the Covid-19 vaccine last year. Admisistration of the vaccine has already started in some countries. Dr. Ugur Sahin, CEO in BioNTech, got interviewed by Bloomberg and explained the future plan of BioNTech. The comany need to increase the manufacturing facility to supply more vaccine doses with people who are requiring the vaccine. However, the company is struggling the plan to increase the manufacturing facility because it depends on how much there will be the demand for the vaccine in the future.